|
Volumn 177, Issue 6, 2017, Pages 880-882
|
Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LEDIPASVIR;
RIBAVIRIN;
SOFOSBUVIR;
ANTIVIRUS AGENT;
BENZIMIDAZOLE DERIVATIVE;
FLUORENE DERIVATIVE;
LEDIPASVIR, SOFOSBUVIR DRUG COMBINATION;
URIDINE PHOSPHATE;
VIRUS RNA;
ADULT;
COHORT ANALYSIS;
FEMALE;
HEPATITIS C;
HEPATITIS C VIRUS GENOTYPE 1;
HEPATITIS C VIRUS GENOTYPE 2;
HOMELESS PERSON;
HUMAN;
LETTER;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
MARGINALLY HOUSED;
MISCELLANEOUS NAMED GROUPS;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
VIRUS LOAD;
ANALOGS AND DERIVATIVES;
ANTIVIRAL RESISTANCE;
BLOOD;
CHRONIC HEPATITIS C;
COMBINATION DRUG THERAPY;
GENETICS;
GENOTYPE;
HEPACIVIRUS;
MIDDLE AGED;
SUSTAINED VIROLOGIC RESPONSE;
ANTIVIRAL AGENTS;
BENZIMIDAZOLES;
COHORT STUDIES;
DRUG RESISTANCE, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FLUORENES;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HOMELESS PERSONS;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RIBAVIRIN;
RNA, VIRAL;
SOFOSBUVIR;
SUSTAINED VIROLOGIC RESPONSE;
TREATMENT OUTCOME;
URIDINE MONOPHOSPHATE;
VIRAL LOAD;
|
EID: 85020720995
PISSN: 21686106
EISSN: None
Source Type: Journal
DOI: 10.1001/jamainternmed.2017.0358 Document Type: Letter |
Times cited : (20)
|
References (6)
|